These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7569432

  • 21. Are antiarrhythmic drugs safe?
    Katritsis D, Camm AJ.
    Clin Cardiol; 1990 Jul; 13(7):491-6. PubMed ID: 2194718
    [Abstract] [Full Text] [Related]

  • 22. Proarrhythmic effects of antiarrhythmic drugs.
    Zipes DP.
    Am J Cardiol; 1987 Apr 30; 59(11):26E-31E. PubMed ID: 2437787
    [Abstract] [Full Text] [Related]

  • 23. Risk factors for the development of proarrhythmic events.
    Morganroth J.
    Am J Cardiol; 1987 Apr 30; 59(11):32E-37E. PubMed ID: 3107364
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 26. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates.
    Roden DM.
    Am J Cardiol; 1996 Aug 29; 78(4A):12-6. PubMed ID: 8780324
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs.
    Nattel S.
    Cardiovasc Res; 1998 Mar 29; 37(3):567-77. PubMed ID: 9659440
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Aggravation of arrhythmia: a complication of antiarrhythmic drugs.
    Podrid PJ.
    J Cardiovasc Electrophysiol; 1993 Jun 29; 4(3):311-9. PubMed ID: 8269302
    [Abstract] [Full Text] [Related]

  • 32. Encainide: its electrophysiologic and antiarrhythmic effects, pharmacokinetics, and safety.
    Tordjman T, Estes NA.
    Pharmacotherapy; 1987 Jun 29; 7(5):149-63. PubMed ID: 3124082
    [Abstract] [Full Text] [Related]

  • 33. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW.
    N Engl J Med; 1993 Aug 12; 329(7):452-8. PubMed ID: 8332150
    [Abstract] [Full Text] [Related]

  • 34. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram.
    Morganroth J, Horowitz LN.
    Am J Cardiol; 1984 Feb 27; 53(5):89B-94B. PubMed ID: 6695821
    [Abstract] [Full Text] [Related]

  • 37. Can antiarrhythmic drugs cause arrhythmia?
    Podrid PJ.
    J Clin Pharmacol; 1984 Jul 27; 24(7):313-9. PubMed ID: 6480877
    [Abstract] [Full Text] [Related]

  • 38. Proarrhythmic responses during electrophysiologic testing.
    Horowitz LN, Greenspan AM, Rae AP, Kay HR, Spielman SR.
    Am J Cardiol; 1987 Apr 30; 59(11):45E-48E. PubMed ID: 3578040
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Proarrhythmia: a paradoxic response to antiarrhythmic agents.
    McCollam PL, Parker RB, Beckman KJ, Hariman RJ, Bauman JL.
    Pharmacotherapy; 1989 Apr 30; 9(3):144-53. PubMed ID: 2666959
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.